These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8103655)

  • 41. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma.
    Vathenen AS; Knox AJ; Wisniewski A; Tattersfield AE
    Am Rev Respir Dis; 1991 Jun; 143(6):1317-21. PubMed ID: 2048819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.
    Higgins BG; Powell RM; Cooper S; Tattersfield AE
    Eur Respir J; 1991 Apr; 4(4):415-20. PubMed ID: 1830277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study.
    Godard P; Greillier P; Pigearias B; Nachbaur G; Desfougeres JL; Attali V
    Respir Med; 2008 Aug; 102(8):1124-31. PubMed ID: 18606533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
    Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
    Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
    Lipworth BJ; Struthers AD; McDevitt DG
    Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
    Magnussen H; Willenbrock U; Jörres R
    Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
    Simone P; Borgia M; Torre L; Ventresca GP
    Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists.
    van Schayck CP; Cloosterman SG; Bijl-Hofland ID; van den Hoogen H; Folgering HT; van Weel C
    Respir Med; 2002 Mar; 96(3):155-62. PubMed ID: 11908511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Which index of peak expiratory flow is most useful in the management of stable asthma?
    Reddel HK; Salome CM; Peat JK; Woolcock AJ
    Am J Respir Crit Care Med; 1995 May; 151(5):1320-5. PubMed ID: 7735580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhaled beta-stimulants--a study of high-dose v. conventional-dose treatment in asthmatic outpatients.
    Bardin PG; Joubert JR
    S Afr Med J; 1991 Jun; 79(11):655-9. PubMed ID: 2047947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regular vs ad-lib albuterol for patients hospitalized with acute asthma.
    Chandra A; Shim C; Cohen HW; Chung V; Maggiore D; Mani K; Dhuper S
    Chest; 2005 Sep; 128(3):1115-20. PubMed ID: 16162695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nedocromil sodium versus albuterol in the management of allergic asthma.
    de Jong JW; Teengs JP; Postma DS; van der Mark TW; Koëter GH; de Monchy JG
    Am J Respir Crit Care Med; 1994 Jan; 149(1):91-7. PubMed ID: 8111606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
    Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
    Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol.
    Wasserman SI; Furukawa CT; Henochowicz SI; Marcoux JP; Prenner BM; Findlay SR; Gross GN; Hudson LD; Myers DJ; Steinberg P
    J Allergy Clin Immunol; 1995 Feb; 95(2):541-7. PubMed ID: 7852670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.
    Spence DP; Johnston SL; Calverley PM; Dhillon P; Higgins C; Ramhamadany E; Turner S; Winning A; Winter J; Holgate ST
    Am J Respir Crit Care Med; 1994 May; 149(5):1142-8. PubMed ID: 8173754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary study on the effect of broxaterol on bronchial hyperresponsiveness in asthmatic children: influence of allergen exposure.
    Benedetti M; Spezia E; Comis A; Marcer G; Boner AL
    Respiration; 1993; 60(6):319-24. PubMed ID: 7904767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine.
    Peel ET; Gibson GJ
    Am Rev Respir Dis; 1980 Jun; 121(6):973-8. PubMed ID: 7416596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.